Marco Pocar

Dr. Marco Pocar

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2006 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
MPMarco Pocar
Marco Pocar
DPDavide Passolunghi
Davide Passolunghi
AMAndrea Moneta
Andrea Moneta
RMRoberto Mattioli
Roberto Mattioli
FDFrancesco Donatelli
Francesco Donatelli

4 October 2005 in JACC
Verified
Journal Article
Closed access
MPMarco Pocar
Marco Pocar
EVEmmanuel Villa
Emmanuel Villa
ADAlexandra Degandt
Alexandra Degandt
PMPhilippe Mauriat
Philippe Mauriat
PPPhilippe Pouard
Philippe Pouard
PVPascal R. Vouhé
Pascal R. Vouhé

14 March 2012 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MPMarco Pocar
Marco Pocar
DPDavide Passolunghi
Davide Passolunghi
ABAlda Bregasi
Alda Bregasi
FDFrancesco Donatelli
Francesco Donatelli
Despite a decline in the last three decades, postinfarction ventricular free wall rupture still complicates more than 3% of acute ST-elevation myocardial infarctions and remains a surgical challenge. TachoSil® (Nycomed, Zurich, Switzerland) is an equine collagen patch coated with human fibrinogen and human thrombin, which has recently been used for haemostasis in cardiovascular surgery, but its potential usefulness in free wall rupture has not been reported. Initial clinical experience with an on-pump sutureless technique without cardioplegia, using wide TachoSil® patching to achieve free wall rupture repair, has been described.

1 May 2010 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
MPMarco Pocar
Marco Pocar
AMAlessandra Di Mauro
Alessandra Di Mauro
DPDavide Passolunghi
Davide Passolunghi
AMAndrea Moneta
Andrea Moneta
AAAl Megalli Tantawi Ali Alsheraei
Al Megalli Tantawi Ali Alsheraei
FDFrancesco Donatelli
Francesco Donatelli
Post-infarction ventricular remodelling has been graded (I-III) according to the loss of systolic left ventricular silhouette curvature changes. Although surgical ventricular restoration (SVR) has been extended to type III ischaemic cardiomyopathy, the results are less satisfactory. We sought to identify geometric and functional predictors of late outcome after SVR. Among 144 patients who underwent SVR since 1998, a subgroup of 31 patients (age: 65.2+/-7.6 years) was analysed. Inclusion criteria were: type III cardiomyopathy, no associated procedure except coronary artery bypass grafting, prior anterior infarction, absent-to-2+ mitral regurgitation, elective operation, follow-up > or =18 months (mean: 44+/-26; longest: 96 months). Probability of events was estimated with the Kaplan-Meier method. A Cox multivariable regression model was constructed selecting eight potential predictors of four adverse events: death, cardiac death, recurrent heart failure (New York Heart Association class III or IV) and left ventricular re-remodelling, defined as a 25% increase of end-systolic volume index after SVR, or an end-systolic volume index > or =50 ml.m(-2). Early and late mortality were zero and 6% (2/31 patients, one cardiac-related death). NYHA class and all echocardiographic functional variables significantly improved early after SVR. Freedom (+/-standard error (SE)) from heart failure was 97%+/-3%, 93%+/-5%, 77%+/-11% and 64%+/-15%, whereas freedom from left ventricular re-remodelling was 97%+/-3%, 80%+/-8%, 60%+/-12% and 39%+/-15%, respectively, 1, 3, 5 and 7 years after SVR. Multivariable analysis identified baseline mitral regurgitation degree and sphericity index as independent predictors of recurrent heart failure (p=0.025; hazard ratio (HR)=7.80 (95% confidence intervals (CIs): 1.29-47.19)) and left ventricular re-remodelling (p=0.047; HR=2.84 (95% CIs: 1.01-7.95)). Both predictors also correlated with a higher recurrence of end-systolic volume index > or =50 ml.m(-2) at late follow-up. Despite advanced cardiomyopathy, SVR determines left ventricular volume reduction and improved systolic function. Baseline absent-to-moderate mitral regurgitation and a more spherical left ventricular geometry predict a less favourable clinical and functional outcome, suggesting a possible rationale for wider indications for combined correction of 2+ mitral regurgitation and undersizing of the mitral annulus, particularly in patients with sphericity index > or =0.75.

1 February 2007 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MPMarco Pocar
Marco Pocar
AMAndrea Moneta
Andrea Moneta
AGAdalberto Grossi
Adalberto Grossi
FDFrancesco Donatelli
Francesco Donatelli

5 November 2013
Verified
Journal Article
Closed access
ALA Leoni
A Leoni
SAS Arlati
S Arlati
DGDaniela Ghisi
Daniela Ghisi
MVM Verwej
M Verwej
DLD Lugani
D Lugani
GAG Aldegheri
G Aldegheri